Structured page family:Cost guide
Plecanatide Cost Guide: Insurance, Cash Pay, and Savings
In the United States, Plecanatide costs depend on brand, pharmacy, insurance design, and whether the patient qualifies for manufacturer savings programs.
Active Market
This page is designed for US treatment decisions and uses US-first pricing and savings sources.
Official pricing
Verify current pricing directly on official Trulance pages before starting, because list pricing, self-pay offers, and eligibility terms can change.
Cash-pay reality
Official cash-pay pricing varies by pharmacy and dose. Contact multiple pharmacies or use a prescription discount service for current rates.
Insurance coverage
Commercial coverage for Plecanatide varies by plan and indication. Prior authorization is commonly required.
Savings and coupons
Manufacturer savings programs may reduce out-of-pocket cost for eligible commercially insured patients.
Prior Authorization
Prior authorization is common and may require documentation of diagnosis, prior treatments, and clinical need.
Price Breakdown
List price (monthly)
~$400-$500/month
Average wholesale price
~$380-$480/month
Pharmacy acquisition estimate
~$350-$450/month
Typical negotiated rate
~$250-$350/month
Price per dose
~$13 per 3 mg
Annual cost at list price
~$4,800-$6,000
Pharmacy Price Comparison
| Pharmacy | Price Range | Notes |
|---|---|---|
| Retail | $380-$500/month | Brand |
| GoodRx | $300-$450/month | Discounted |
Insurance Coverage Landscape
Commercial plans
~70-80% after step therapy
Medicare Part D
Covered
Medicaid
Most states cover with prior auth
VA coverage
On formulary
TRICARE
Covered
Employer plan typical tier
Tier 2-3; copay $30-75
Prior Authorization Guide
Required Documentation
- •CIC or IBS-C diagnosis
- •Failed fiber and PEG
- •Sometimes failed lubiprostone or linaclotide
Common Denial Reasons
- •Step therapy incomplete
- •Not failed cheaper alternatives
Appeal Template Points
- •FDA-approved
- •Failed first-line therapy
- •Better tolerability than linaclotide (lower diarrhea rate)
Expected timeline: 3-5 days
Savings Programs and Patient Assistance
Trulance Savings Card
copayEligibility: Commercially insured
Savings: $25/month
Income limit: None
Enrollment: simple
Bausch Health program
PAP
manufacturerEligibility: Uninsured, ≤400% FPL
Savings: Free
Income limit: ≤400% FPL
Enrollment: moderate
Annual
Generic and Biosimilar Status
No generic currently available
Expected: Generic expected late 2020s-early 2030s
Cost by Dose
| Dose/Regimen | Monthly | Annual |
|---|---|---|
| 3 mg daily | $400-$500 | $4,800-$6,000 |
Annual Cost Projection
Year 1
$300-$6,000
Year 2
$300-$6,000
Year 3
$300-$6,000
Assumptions
- •Brand pricing
- •Insurance
Cost-Saving Strategies
- 1.Trulance savings card ($25/month)
- 2.Document linaclotide intolerance if switching
- 3.GoodRx comparison
International Price Comparison
| Country | Price Range | Notes |
|---|---|---|
| UK | ~£80-120/month (~$100-150) | NHS |
Need help comparing plecanatide paths?
Use the provider matcher to package treatment interest, insurance, budget, urgency, and state context before you commit to a prescribing path.
Find a plecanatide providerNext Step
Use the cost calculator
Use provider matching when you need help comparing insured and self-pay treatment paths.
Open tool →Retention Path
Join the Plecanatide tracker waitlist
Capture refill timing, weekly dose history, and symptom notes in one planned workflow.
View tracker landing →Trust Summary
Reviewed 2026-04-27 by PeptideScholar editorial review. This page currently cites 2 official sources.
Pricing, savings eligibility, and coverage rules can change quickly. Verify all current figures and terms directly on official brand pages before acting.
Plecanatide Cost FAQ
Sources
- 1. A Randomized Phase III Clinical Trial of Plecanatide, a Uroguanylin Analog, in Patients With Chronic Idiopathic Constipation.Am J Gastroenterol • 2017Claim type: clinicalView source →
- 2. FDA Information on PlecanatideFDA • 2026Claim type: regulatoryView source →
This content is for informational purposes only and does not constitute medical advice.